The ClpP activator ONC‐212 (TR‐31) inhibits BCL2 and B‐cell receptor signaling in CLL
Journal article published in 2021 by
Narjis Fatima,
Yandong Shen 
,
Kyle Crassini ,
Edwin J. Iwanowicz,
Henk Lang,
Donald S. Karanewsky,
Richard I. Christopherson,
Stephen P. Mulligan,
Oliver G. Best
,
Kyle Crassini ,
Edwin J. Iwanowicz,
Henk Lang,
Donald S. Karanewsky,
Richard I. Christopherson,
Stephen P. Mulligan,
Oliver G. Best
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 